Trialspark stock

Trialspark Stock


Looking to sell Trialspark stock or options?

Contact us
Founded: 2013Funding to Date: $247M
Visit website

Trialspark is the creator of a biotech platform that revolutionizes drug development to expedite patient treatments. The company's platform has expanded a network of trial sites by transforming existing practices into clinical trial locations with a mobile team of certified research coordinators, all enhanced by state-of-the-art software, data, and technology. This allows researchers to broaden their access to human subjects for research studies, paid clinical trials, psychological research, and focus groups.

Investors include:
Dragoneer Investment Group logo
Sequoia Capital logo
Further Key Investors:

Sound Ventures, S32, Sam Altman, ArrowMark Partners, Michael Moritz, TQ Ventures, Mantis VC, Felicis, Cherubic Ventures, John Doerr, Thrive Capital, Lachy Groom, Emerson Collective, 3cubed Ventures, Casdin Capital, Spark Capital, AlphaLab.

Collective Representative

Looking to sell Trialspark Stock or Options?

We have an even better solution: The Collective Exchange Fund

Get in touch and see if we can help you